384 related articles for article (PubMed ID: 9202234)
1. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
Uht RM; Anderson CM; Webb P; Kushner PJ
Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
[TBL] [Abstract][Full Text] [Related]
3. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
4. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
5. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
6. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter.
Wei P; Inamdar N; Vedeckis WV
Mol Endocrinol; 1998 Sep; 12(9):1322-33. PubMed ID: 9731701
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.
Petz LN; Ziegler YS; Loven MA; Nardulli AM
Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585
[TBL] [Abstract][Full Text] [Related]
8. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis.
Philips A; Chalbos D; Rochefort H
J Biol Chem; 1993 Jul; 268(19):14103-8. PubMed ID: 8314777
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
10. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription.
Ambrosino C; Cicatiello L; Cobellis G; Addeo R; Sica V; Bresciani F; Weisz A
Mol Endocrinol; 1993 Nov; 7(11):1472-83. PubMed ID: 8114761
[TBL] [Abstract][Full Text] [Related]
11. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene.
Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL
Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057
[TBL] [Abstract][Full Text] [Related]
12. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.
Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D
Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells.
Hu DG; Mackenzie PI
Mol Pharmacol; 2009 Aug; 76(2):425-39. PubMed ID: 19487245
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of neurotensin/neuromedin N gene expression by c-Jun and glucocorticoids: novel effects of Fos family proteins.
Harrison RJ; McNeil GP; Dobner PR
Mol Endocrinol; 1995 Aug; 9(8):981-93. PubMed ID: 7476995
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary conservation of an atypical glucocorticoid-responsive element in the human tyrosine hydroxylase gene.
Sheela Rani CS; Soto-Pina A; Iacovitti L; Strong R
J Neurochem; 2013 Jul; 126(1):19-28. PubMed ID: 23647419
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid regulation of c-fos, c-jun and transcription factor AP-1 in the AtT-20 corticotrope cell.
Autelitano DJ
J Neuroendocrinol; 1994 Dec; 6(6):627-37. PubMed ID: 7894465
[TBL] [Abstract][Full Text] [Related]
17. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
18. Cross talk between glucocorticoid and estrogen receptors occurs at a subset of proinflammatory genes.
Cvoro A; Yuan C; Paruthiyil S; Miller OH; Yamamoto KR; Leitman DC
J Immunol; 2011 Apr; 186(7):4354-60. PubMed ID: 21357268
[TBL] [Abstract][Full Text] [Related]
19. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
